Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$126.27 - $191.71 $768,479 - $1.17 Million
-6,086 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$73.3 - $89.48 $14,146 - $17,269
-193 Reduced 3.07%
6,086 $506,000
Q2 2020

Aug 12, 2020

SELL
$48.82 - $82.53 $239,510 - $404,892
-4,906 Reduced 43.86%
6,279 $516,000
Q1 2020

May 14, 2020

BUY
$39.1 - $62.9 $437,333 - $703,536
11,185 New
11,185 $576,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.48B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Employees Retirement System Of Texas Portfolio

Follow Employees Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Employees Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Employees Retirement System Of Texas with notifications on news.